BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tantai XX, Yang LB, Wei ZC, Xiao CL, Chen LR, Wang JH, Liu N. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis. World J Gastroenterol 2019; 25(21): 2683-2698 [PMID: 31210719 DOI: 10.3748/wjg.v25.i21.2683]
URL: https://www.wjgnet.com/1007-9327/full/v25/i21/2683.htm
Number Citing Articles
1
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liverJournal of Digestive Diseases 2022; 23(4): 196 doi: 10.1111/1751-2980.13093
2
Akira Sakamaki, Kenya Kamimura, Takeshi Yokoo, Akihiko Osaki, Seiichi Yoshikawa, Yoshihisa Arao, Toru Setsu, Hiroteru Kamimura, Nobuo Waguri, Manabu Takeuchi, Kazuhiro Funakoshi, Shuji Terai. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitorsMedicine 2021; 100(32): e26902 doi: 10.1097/MD.0000000000026902
3
Rok Orel, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Alexandra Papadopoulou, Carmen Ribes-Koninckx, Mike Thomson, Michael Wilschanski, Nikhil Thapar. Drugs in Focus: Proton Pump InhibitorsJournal of Pediatric Gastroenterology & Nutrition 2021; 72(5): 645 doi: 10.1097/MPG.0000000000003063
4
K. Toda. Are proton pump inhibitors suitable medicines to prevent upper gastrointestinal events due to non-steroidal anti-inflammatory drugs?Osteoarthritis and Cartilage 2020; 28(1): e1 doi: 10.1016/j.joca.2019.09.010
5
Xiaoli Wu, Daofu Zhang, Yuexiao Yu, Lianqing Lou, Xiaofei Li. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studiesBioscience Reports 2020; 40(6) doi: 10.1042/BSR20193890
6
Reidar Fossmark, Tom C. Martinsen, Helge L. Waldum. Adverse Effects of Proton Pump Inhibitors—Evidence and PlausibilityInternational Journal of Molecular Sciences 2019; 20(20): 5203 doi: 10.3390/ijms20205203
7
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk managementTerapevticheskii arkhiv 2021; 93(8): 963 doi: 10.26442/00403660.2021.08.200917
8
Agastya Patel, Piotr Spychalski, Jarek Kobiela. Letter: mind the gap – search and publication date of systematic reviews and meta‐analysisAlimentary Pharmacology & Therapeutics 2021; 54(5): 730 doi: 10.1111/apt.16537
9
Rui Dai, Alan A. Sag, Jonathan G. Martin, Nicholas T. Befera, Waleska M. Pabon-Ramos, Paul V. Suhocki, Tony P. Smith, Charles Y. Kim, Andrew J. Muir, James Ronald. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohortClinical Imaging 2021; 77: 187 doi: 10.1016/j.clinimag.2021.04.034